3 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 3 |
Follow Phobic Disorders: new trials by email Literature Review of Phobic Disorders trials Research Report on Phobic Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD) PH94B - Social Anxiety Disorder | Phase 3 | Terminated | VistaGen Therapeutics, Inc. | 481 | 2021-10-01 | 2025-10-21 |
| PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2 PH94B Nasal Spray, Placebo Nasal Spray - Social Anxiety Disorder | Phase 3 | Terminated | VistaGen Therapeutics, Inc. | 228 | 2021-08-30 | 2025-11-24 |
| Efficacy of Quetiapine in Generalised Social Anxiety Disorder quetiapine - Social Anxiety Disorder | Phase 3 | Terminated | AstraZeneca | 50 | 2006-06-01 | 2011-01-27 |
Phobia, Social (3)
Anxiety Disorders (3) · Mental Disorders (3)
VistaGen Therapeutics, Inc. (2) · AstraZeneca (1)
United States (2) · Netherlands (1)